Pharma and Biotech
Dividend | |
Latest XD Date (Final) | n/a |
Latest Pay Date (Final) | n/a |
Meetings | |
AGM | 08-Feb-2024 |
EGM | n/a |
GMs | 17-Feb-2020 |
Announcements | |
Trading announcement | 24-Oct-2022 |
IMSs | n/a |
Drilling Report | n/a |
Results | |
Final results | 29-Nov-2023 |
Interim results | 22-May-2024 |
Q1 Results | 22-May-2024 |
Q2 Results | 22-May-2024 |
Q3 Results | 24-Aug-2023 |
Q4 Results | 29-Nov-2023 |
Annual Report | 13-Dec-2022 |
Year End | 30-Sep-2024 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 40.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 48.00p |
52 Week Low | 34.00p |
Volume | 100,222 |
Shares Issued | 739.78m |
Market Cap | £295.91m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
15:11 | 5,535 @ 40.00p |
15:11 | 5,307 @ 40.00p |
15:11 | 6,025 @ 40.00p |
15:11 | 5,593 @ 40.00p |
15:10 | 5,000 @ 40.00p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research